169 related articles for article (PubMed ID: 29802052)
1. Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database.
Preisser F; Bandini M; Mazzone E; Nazzani S; Marchioni M; Tian Z; Saad F; Pompe RS; Shariat SF; Heinzer H; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
Eur Urol Focus; 2019 Sep; 5(5):807-814. PubMed ID: 29802052
[TBL] [Abstract][Full Text] [Related]
2. Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables.
Würnschimmel C; Nocera L; Wenzel M; Ruvolo CC; Tian Z; Saad F; Briganti A; Shariat SF; Mirone V; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
J Racial Ethn Health Disparities; 2023 Apr; 10(2):708-717. PubMed ID: 35182370
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients.
Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Mazzone E; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2018 Aug; 1(3):215-222. PubMed ID: 31102624
[TBL] [Abstract][Full Text] [Related]
4. Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table data.
Würnschimmel C; Wenzel M; Wang N; Tian Z; Karakiewicz PI; Graefen M; Huland H; Tilki D
Prostate; 2021 Aug; 81(11):785-793. PubMed ID: 34101879
[TBL] [Abstract][Full Text] [Related]
5. Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men with Prostate Cancer.
Dalela D; Karabon P; Sammon J; Sood A; Löppenberg B; Trinh QD; Menon M; Abdollah F
Eur Urol; 2017 Apr; 71(4):511-514. PubMed ID: 27638094
[TBL] [Abstract][Full Text] [Related]
6. External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients.
Knipper S; Dzyuba-Negrean C; Palumbo C; Pecoraro A; Rosiello G; Tian Z; Briganti A; Saad F; Tilki D; Graefen M; Karakiewicz PI
Int Urol Nephrol; 2020 Jan; 52(1):59-66. PubMed ID: 31542882
[TBL] [Abstract][Full Text] [Related]
7. Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients.
Würnschimmel C; Collà Ruvolo C; Nocera L; Wenzel M; Tian Z; Saad F; Briganti A; Shariat SF; Mirone V; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
Eur Urol Focus; 2022 Jan; 8(1):191-199. PubMed ID: 33610487
[TBL] [Abstract][Full Text] [Related]
8. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
9. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
[TBL] [Abstract][Full Text] [Related]
10. Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations.
Leyh-Bannurah SR; Karakiewicz PI; Pompe RS; Preisser F; Zaffuto E; Dell'Oglio P; Briganti A; Nafez O; Fisch M; Steuber T; Graefen M; Budäus L
World J Urol; 2019 Mar; 37(3):469-479. PubMed ID: 29992380
[TBL] [Abstract][Full Text] [Related]
11. Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer.
Muralidhar V; Mahal BA; Butler S; Lamba N; Yang DD; Leeman J; D'Amico AV; Nguyen PL; Trinh QD; Orio PF; King MT
J Urol; 2019 Nov; 202(5):973-978. PubMed ID: 31144590
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Lymph Node Metastases Burden at Radical Prostatectomy.
Preisser F; Marchioni M; Nazzani S; Bandini M; Tian Z; Pompe RS; Montorsi F; Saad F; Abdollah F; Steuber T; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):399-406. PubMed ID: 29306731
[TBL] [Abstract][Full Text] [Related]
13. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
Culp SH; Schellhammer PF; Williams MB
Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
[TBL] [Abstract][Full Text] [Related]
14. The Patient Burden of Bladder Outlet Obstruction after Prostate Cancer Treatment.
Liberman D; Jarosek S; Virnig BA; Chu H; Elliott SP
J Urol; 2016 May; 195(5):1459-1463. PubMed ID: 26682759
[TBL] [Abstract][Full Text] [Related]
15. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
16. A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer.
Knipper S; Pecoraro A; Palumbo C; Rosiello G; Luzzago S; Tian Z; Briganti A; Saad F; Tilki D; Graefen M; Karakiewicz PI
Clin Genitourin Cancer; 2019 Oct; 17(5):395-401. PubMed ID: 31416752
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.
Gielchinsky I; Chang J; Cusick T; Delprado W; Nguyen Q; Yuen C; Savdie R; Böhm M; Haynes AM; Scheltema MJ; Stricker PD
BJU Int; 2018 Nov; 122 Suppl 5():35-41. PubMed ID: 30303599
[TBL] [Abstract][Full Text] [Related]
18. Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.
Dell'Oglio P; Bishr M; Boehm K; Trudeau V; Larcher A; Tian Z; Sosa J; Moschini M; Saad F; Capitanio U; Briganti A; Graefen M; Montorsi F; Karakiewicz PI
Eur Urol Focus; 2018 Dec; 4(6):834-841. PubMed ID: 28753853
[TBL] [Abstract][Full Text] [Related]
19. Successful external validation of a model to predict other cause mortality in localized prostate cancer.
Kent M; Penson DF; Albertsen PC; Goodman M; Hamilton AS; Stanford JL; Stroup AM; Ehdaie B; Scardino PT; Vickers AJ
BMC Med; 2016 Feb; 14():25. PubMed ID: 26860993
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of radical prostatectomy versus external beam radiotherapy (75.6 Gy) combined with hormone therapy for prostate cancer of intermediate D'Amico risk classification].
Boissier R; Karsenty G; Muracciole X; Daniel L; Delaporte V; Maurin C; Coulange C; Lechevallier E
Prog Urol; 2013 Sep; 23(10):861-8. PubMed ID: 24034798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
